What is Baron & Budd?
Founded in 1977, Baron & Budd, P.C. has established itself as one of the most accomplished plaintiffs' law firms in the United States. With over four decades of experience, the firm specializes in complex litigation, ranging from pharmaceutical liability and defective medical devices to environmental contamination and whistleblower advocacy. Their market position is defined by a history of spearheading landmark cases that have shaped national legal precedents. By maintaining a diverse portfolio of practice areas, the firm mitigates risk while maximizing its impact on consumer protection and corporate accountability. Their operational model relies on deep technical expertise and the financial fortitude to sustain protracted legal battles against well-funded adversaries.
How much funding has Baron & Budd raised?
Baron & Budd has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Baron & Budd
PPP
Public-Private Partnership
What's next for Baron & Budd?
With the recent influx of capital, Baron & Budd is poised to expand its reach into emerging areas of consumer fraud and environmental litigation. The firm's strategic roadmap likely involves upgrading its digital discovery capabilities and increasing its headcount of specialized litigators to address the growing complexity of federal whistleblower cases and e-cigarette litigation. As the firm continues to navigate the evolving regulatory environment, this financial stability provides the necessary runway to pursue high-impact cases that require significant upfront investment. Investors and stakeholders can expect the firm to maintain its aggressive litigation posture, further cementing its reputation as a formidable force in the pursuit of justice for individuals and entities alike.
See full Baron & Budd company page
